Michel P. Hermans

12.9k total citations · 1 hit paper
195 papers, 5.2k citations indexed

About

Michel P. Hermans is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michel P. Hermans has authored 195 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Endocrinology, Diabetes and Metabolism, 58 papers in Surgery and 36 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michel P. Hermans's work include Diabetes, Cardiovascular Risks, and Lipoproteins (61 papers), Diabetes Treatment and Management (34 papers) and Lipoproteins and Cardiovascular Health (33 papers). Michel P. Hermans is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (61 papers), Diabetes Treatment and Management (34 papers) and Lipoproteins and Cardiovascular Health (33 papers). Michel P. Hermans collaborates with scholars based in Belgium, Democratic Republic of the Congo and United States. Michel P. Hermans's co-authors include Michel F. Rousseau, Sylvie A. Ahn, Dominique Maiter, Jean-Paul Thissen, Audrey Loumaye, Amandine Everard, Patrice D. Cani, Nathalie M. Delzenne, Clara Depommier and Céline Druart and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and American Journal of Clinical Nutrition.

In The Last Decade

Michel P. Hermans

180 papers receiving 5.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study

2019 1.6k citations Clara Depommier, Amandine Everard et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michel P. Hermans Belgium	32	1.9k	1.8k	1.3k	1.2k	777	195	5.2k
Ranganath Muniyappa United States	33	1.5k 0.8×	2.0k 1.1×	917 0.7×	1.5k 1.2×	1.0k 1.3×	85	6.5k
Qiang Li China	36	1.6k 0.9×	1.7k 0.9×	1.7k 1.3×	956 0.8×	1.0k 1.3×	319	7.0k
Henrik Vestergaard Denmark	43	3.3k 1.8×	1.6k 0.9×	1.3k 1.0×	1.5k 1.2×	602 0.8×	157	6.5k
Manjinder S. Sandhu United Kingdom	36	1.2k 0.6×	1.2k 0.7×	975 0.7×	741 0.6×	731 0.9×	75	4.8k
Hae Jin Kim South Korea	39	1.4k 0.7×	1.5k 0.8×	787 0.6×	1.2k 0.9×	1.2k 1.6×	228	5.4k
Masato Eto Japan	49	1.5k 0.8×	1.2k 0.7×	829 0.6×	1.7k 1.3×	1.0k 1.4×	153	7.2k
Amir Tirosh Israel	36	1.1k 0.6×	1.3k 0.7×	732 0.5×	1.4k 1.1×	878 1.1×	113	5.2k
Sydney Tang Hong Kong	51	2.0k 1.1×	676 0.4×	1.1k 0.8×	649 0.5×	974 1.3×	314	9.4k
Thomas A. Buchanan United States	50	1.7k 0.9×	2.8k 1.6×	2.5k 1.9×	1.5k 1.2×	1.0k 1.3×	124	8.8k
Ashok Balasubramanyam United States	36	1.1k 0.6×	1.7k 0.9×	1.0k 0.8×	1.0k 0.8×	694 0.9×	162	4.6k

Countries citing papers authored by Michel P. Hermans

Since Specialization

Citations

This map shows the geographic impact of Michel P. Hermans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel P. Hermans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel P. Hermans more than expected).

Fields of papers citing papers by Michel P. Hermans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel P. Hermans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel P. Hermans. The network helps show where Michel P. Hermans may publish in the future.

Co-authorship network of co-authors of Michel P. Hermans

This figure shows the co-authorship network connecting the top 25 collaborators of Michel P. Hermans. A scholar is included among the top collaborators of Michel P. Hermans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel P. Hermans. Michel P. Hermans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oriot, Philippe, et al.. (2025). Short-term CGM as a tool to optimize glycemic control and defer intensive insulin therapy in people with poorly controlled type 2 diabetes: a Belgian real-life study. Acta Clinica Belgica. 80(4). 71–82.

Hermans, Michel P., et al.. (2024). Dynamics in the Prevalence of Insulin Resistance between 2005 and 2023 in Type 2 Diabetics in South Kivu in the East of the Democratic Republic of Congo: Cross-Sectional Studies. Journal of Diabetes Mellitus. 14(1). 28–40. 1 indexed citations

Massip, Laurent, et al.. (2023). Association between Metabolic Syndrome Components and Serum High-Sensitivity C-Reactive Protein or Interleukin-6 Levels among Congolese Adults. Advances in Biological Chemistry. 13(3). 71–81. 1 indexed citations

Rossi, Camélia, Ernestina Repetto, Laurent Crenier, et al.. (2023). Mortality-related risk factors of inpatients with diabetes and COVID-19: A multicenter retrospective study in Belgium. Annales d Endocrinologie. 85(1). 36–43.

Hermans, Michel P., Laurence Seidel, Adelin Albert, et al.. (2023). The antihyperlipidemic effect of a combined supplement of standardized dry extracts of amla (Emblica officinalis), walnut (Juglans regia), olive (Olea europaea) and red yeast rice (Monascus purpureus) powder: Reduction in circulatory low-density lipoprotein-cholesterol (LDL-C) and remnant cholesterol (RC) levels in patients with hypercholesterolemia. Frontiers in Pharmacology. 14. 1 indexed citations

Aguíar, Carlos, Nasreen Al-Sayed, М. В. Ежов, et al.. (2023). Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook. Atherosclerosis. 383. 117312–117312. 77 indexed citations

Nachega, Jean B., Placide Mbala‐Kingebeni, Philip J. Rosenthal, et al.. (2023). The Human Mpox Global Outbreak: Available Control Tools and the Opportunity to Break a Cycle of Neglect in Endemic Countries. American Journal of Tropical Medicine and Hygiene. 109(4). 719–724.

Nachega, Jean B., Nadia A. Sam‐Agudu, Mark J. Siedner, et al.. (2022). Prioritizing Pregnant Women for Coronavirus Disease 2019 Vaccination in African Countries. Clinical Infectious Diseases. 75(8). 1462–1466. 12 indexed citations

Depommier, Clara, Rosa Maria Vitale, Fabio Arturo Iannotti, et al.. (2021). Beneficial Effects of Akkermansia muciniphila Are Not Associated with Major Changes in the Circulating Endocannabinoidome but Linked to Higher Mono-Palmitoyl-Glycerol Levels as New PPARα Agonists. Cells. 10(1). 185–185. 52 indexed citations

10.

Depommier, Clara, Nicolas Flamand, Rudy Pelicaen, et al.. (2021). Linking the Endocannabinoidome with Specific Metabolic Parameters in an Overweight and Insulin-Resistant Population: From Multivariate Exploratory Analysis to Univariate Analysis and Construction of Predictive Models. Cells. 10(1). 71–71. 8 indexed citations

11.

Caty, Gilles, et al.. (2020). Assessing thermal sensitivity using transient heat and cold stimuli combined with a Bayesian adaptive method in a clinical setting: A proof of concept study. European Journal of Pain. 24(9). 1812–1821. 8 indexed citations

12.

Lemogoum, Daniel, Felicité Kamdem, Bâ Hamadou, et al.. (2020). Epidemiology of Acutely Decompensated Systolic Heart Failure Over the 2003–2013 Decade in Douala General Hospital, Cameroon. ESC Heart Failure. 8(1). 481–488. 4 indexed citations

13.

Hermans, Michel P., et al.. (2014). Cardiovascular risk factors: Belgian target achievement.. Acta Cardiologica. 69(5). 473–81. 6 indexed citations

14.

Preumont, Vanessa, Michel P. Hermans, Michael Bergman, & Martin Buysschaert. (2013). Predictive factors associated with primary failure to exenatide and non goal attainment in patients with type 2 diabetes.. PubMed. 67(6). 411–5. 6 indexed citations

15.

Hermans, Michel P., et al.. (2011). El coaching ejecutivo en América Latina. Harvard business review. 89(6). 66–77. 31 indexed citations

16.

Hermans, Michel P., et al.. (2010). Evaluating Benchmarking to Optimize Management of Type 2 Diabetes Patients: The Belgian Data of the Optimise study. Document Server@UHasselt (UHasselt). 1 indexed citations

17.

Hermans, Michel P., et al.. (2010). Más allá del talento individual: lecciones de Sudáfrica 2010. Harvard business review. 88(9). 50–62. 4 indexed citations

18.

Preumont, Vanessa, Michel P. Hermans, Martin Buysschaert, & Jacques Jamart. (2009). Special Considerations in the Management and Education of Older Persons With Diabetes. Diabetes & Metabolism. 35. 7 indexed citations

19.

Hermans, Michel P., et al.. (2007). [The Robert Wood Johnson Foundation Diabetes Initiative: Demonstration Projects Emphasizing Self-management]. Diabetes & Metabolism. 33. 5 indexed citations

20.

Buysschaert, Martin & Michel P. Hermans. (2003). Comment je traite et prends en charge une hyperhomocystéinémie.. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 229. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact